VRTX — VERTEX PHARMACEUTICALS INC COM

Ownership history in Knuff & Co LLC · 29 quarters on record

This page tracks every 13F SEC filing in which Knuff & Co LLC reported a position in VERTEX PHARMACEUTICALS INC COM (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

2.25% (2025 Q1)

Avg. % of fund

1.62%

First filed

2018 Q4

Last filed

2025 Q4

Quarters held

29

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	ADDED	14,197	+13	+0.1%	1.90%	$6.4M	$453.36
2025 Q3	ADDED	14,184	+188	+1.3%	1.61%	$5.6M	$391.64
2025 Q2	ADDED	13,996	+171	+1.2%	1.96%	$6.2M	$445.20
2025 Q1	REDUCED	13,825	-116	-0.8%	2.25%	$6.7M	$484.82

% of Fund (quarterly) VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%

← Back to Knuff & Co LLC Holdings